alphaveINDOUS₹80.34

Indo Us Biotech Limited

₹ CrorePeersKOHINOOR NATHBIOGEN AGRITECH SARVESHWAR SUKHJITS REGAAL BSHSL GULPOLYMcap ₹161 Cr

View

In ₹ Crore except Per Share 12 Months Ending	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Non-current Assets
+ Property, Plant & Equipment	10.2	11.2	11.2
+ Capital Work-in-Progress	—	0.5	0.5
+ Long-term Loans	0.0	0.2	0.2
Non-current Financial Assets	0.0	0.2	0.2
+ Deferred Tax Assets	0.7	0.5	0.5
+ Other Non-current Assets	0.2	0.0	0.0
Total Non-current Assets	11.1	12.4	12.4
Current Assets
+ Inventories	70.7	100.0	100.0
+ Trade Receivables	15.0	13.8	13.8
+ Cash & Cash Equivalents	0.2	6.1	6.1
+ Other Current Financial Assets	0.8	0.8	0.8
Current Financial Assets	16.0	20.7	20.7
+ Other Current Assets	0.0	0.1	0.1
Total Current Assets	86.7	120.7	120.7
Total Assets	97.8	133.1	133.1
Equity
+ Equity Share Capital	20.1	20.1	20.1
+ Other Equity / Reserves	58.5	72.5	72.5
Equity — Owners of Parent	78.5	92.5	92.5
Total Equity	78.5	92.5	92.5
Liabilities
+ Borrowings — Non-current	2.9	1.0	1.0
Non-current Financial Liabilities	2.9	1.0	1.0
+ Provisions — Non-current	0.1	0.1	0.1
Non-current Liabilities	3.0	1.0	1.0
+ Borrowings — Current	11.9	36.1	36.1
+ Trade Payables	1.2	0.4	0.4
Current Financial Liabilities	13.1	36.5	36.5
+ Provisions — Current	0.0	0.0	0.0
+ Current Tax Liabilities	0.3	0.4	0.4
+ Other Current Liabilities	3.0	2.5	2.5
Current Liabilities	16.3	39.5	39.5
Total Liabilities	19.3	40.6	40.6
Total Equity & Liabilities	97.8	133.1	133.1
Trade Payables — MSME split
+ Dues to Micro & Small — Current	0.2	0.0	0.0
+ Dues to Other Creditors — Current	1.0	0.4	0.4

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.